Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 7Gastritis 5Peptic Ulcer 3Gastroesophageal Reflux 3Dyspepsia 3Breast Neoplasms 3Barrett Esophagus 3Stomach Ulcer 2Colorectal Neoplasms 2Vomiting 1Radiation Esophagitis 1Precancerous Conditions 1Peptic Ulcer Hemorrhage 1Neoplasm Metastasis 1Nausea 1Lymphoma, B-Cell, Marginal Zone 1Hemorrhage 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Esophagitis 1Esophageal Neoplasms 1Dysbiosis 1Colonic Neoplasms 1

Interventions

bismuth tripotassium dicitrate 1Tetracycline 1Tablets 1Observation 1Metronidazole 1Lacteol 1Esomeprazole 1Colonoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dysbiosis × Esomeprazole × Clear all
NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation
312 enrolled

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡